Baxter to Invest $50 Million into Indiana Fill/Finish Manufacturing Facilities Expansion

November 24, 2020
BioPharm International Editors

The expansion will include a new 25,000-ft2 warehouse, a filling line for flexible plastic containers, a high-speed automated syringe fill line with the ability to fill up to 600 units per minute, and a high-speed automated visual inspection line.

Baxter announced on Nov. 24, 2020 that it is investing $50 million into the expansion of its sterile fill/finish manufacturing facilities in Bloomington, IN.

The expansion will include a new 25,000 ft-2 warehouse, a filling line for flexible plastic containers, a high-speed automated syringe fill line with the ability to fill up to 600 units per minute, and a high-speed automated visual inspection line, a company press release said. Construction is expected to be completed in 2021, and the new facilities will create 100 new jobs at the site.

“We pride ourselves on being a contract manufacturing partner with the specialized expertise, proven experience, and facilities to help our clients successfully achieve their sterile manufacturing objectives,” said Marie Keeley, vice-president, BioPharma Solutions, Baxter, in the press release. “Our Bloomington facility is already a global leader in sterile contract manufacturing, and this expansion will add capacity and state-of-the-art technology that will better enable us to meet the diverse needs of our clients and the patients they serve.”

Source: Baxter